|
Recurrent Esophageal Cancer
Current Clinical Trials
All recurrent esophageal cancer patients present difficult problems in
palliation. All patients, whenever possible, should be considered candidates
for clinical trials as outlined in treatment overview.
Standard treatment options:
-
Palliative use of any of the standard therapies, including supportive care.
Treatment options under clinical evaluation:
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent esophageal cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
 Back to Top
< Previous Section | Next Section > |
